65 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
New dermatological agents for the treatment of psoriasis.

Allergan
Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent.

Allergan
Synthesis and biological activity of retinoic acid receptor-alpha specific amides.

Allergan
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.

Allergan
Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity.

Allergan
A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids.

Allergan
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.

Allergan
High affinity retinoic acid receptor antagonists: analogs of AGN 193109.

Allergan
Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonists.

Allergan
Identification of retinoic acid receptor beta subtype specific agonists.

Allergan
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.

Allergan
Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonist.

Allergan
Identification of a retinoic acid receptor alpha subtype specific agonist.

Allergan
Synthesis and carbonic anhydrase inhibitory activity of 4-substituted 2-thiophenesulfonamides.

Allergan
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.

Allergan
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors.

Allergan
Identification of highly potent retinoic acid receptor alpha-selective antagonists.

Allergan
Conformational control in structure-based drug design.

Allergan
Human plasma kallikrein inhibitors

Biocryst Pharmaceuticals
GCN2 inhibitors and uses thereof

Merck Patent
Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereof

Shanghai Haiyan Pharmaceutical Technology
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure

Yeda Research and Development
Heterocyclic compounds as immunomodulators

Incyte
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

University Of Texas
Cyclopropanamine compound and use thereof

Takeda Pharmaceutical
α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

Merck Serono
Conferin, potent antioxidant and anti-inflammatory isoflavone from Caragana conferta Benth.

University of Karachi
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.

National Institutes of Health
Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

University of California
Heteroaromatic methyl cyclic amine derivative

Taisho Pharmaceutical
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators

Roche Palo Alto
Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.

Universidade De Lisboa
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

Pfizer
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase.

University of California Santa Cruz
Pyridyl aminopyridines as Syk inhibitors

Merck Sharp & Dohme
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

Bristol-Myers Squibb
Substituted benzimidazole-type piperidine compounds and uses thereof

Purdue Pharma
Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

Fm Therapeutics
n-Alkylboronic acid inhibitors reveal determinants of ligand specificity in the quorum-quenching and siderophore biosynthetic enzyme PvdQ.

The University of Texas
Hydroxybenzaldoximes Are D-GAP-Competitive Inhibitors of E. coli 1-Deoxy-D-Xylulose-5-Phosphate Synthase.

The Johns Hopkins University School of Medicine
Compounds and method for treatment of HIV

Critical Outcome Technologies
Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same

Jeil Pharmaceutical
Aminopyrimidine derivatives as LRRK2 modulators

Genentech
Heteroaryl compounds and their uses

Novartis
Scriptaid isosteres and their use in therapy

Karus Therapeutics
HDAC inhibitors and therapeutic methods of using same

University of Illinois
Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors

N30 Pharmaceuticals
2,5-disubstituted piperidine orexin receptor antagonists

Merck Sharp & Dohme
Carboxy isatin hydrazones and their esters as Shp2 inhibitors

H. Lee Moffitt Cancer Center and Research Institute
Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.

Ewha Womans University
Bacterial thioredoxin reductase inhibitors and methods for use thereof

Thioredoxin Systems
Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same

Vanderbilt University
Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors

CSIR, Pretoria (Za)
Design and synthesis of new 2-aryl, 3-benzyl- (1,3-oxazolidine or 1,3-thiazolidine)-4-ones as selective cyclooxygenase (COX-2) inhibitor

Shahid Beheshti University
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.

North-West University
Lipoxygenase inhibiting and antioxidant iridoids from Buddleja crispa.

Chinese Academy of Medical Sciences
The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

Preclinical R & D, Astra Arcus
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI.

Institut Des BiomolÉCules Max Mousseron (Ibmm)
Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor.

University of Heidelberg